ATI LPN
Cardiovascular Assessment Questions Questions
Question 1 of 5
Which condition would contraindicate the use of a beta-blocker like metoprolol?
Correct Answer: A
Rationale: Beta-blockers can cause bronchoconstriction and exacerbate asthma or chronic obstructive pulmonary disease (COPD).
Question 2 of 5
A normal weight 28 y/o female with secondary oligomenorrhea and galactorrhea presents to your office. Her prolactin level is elevated. MRI of the sella reveals a 5 mm pituitary microadenoma. Prolactin level is elevated and you suspect this is a prolactinoma. Other pituitary hormones are normal. Which of the following statements regarding prolactinomas is/are true?
Correct Answer: B
Rationale: Prolactinomas cause hyperprolactinemia, leading to oligomenorrhea and galactorrhea. Dopamine agonists like cabergoline or bromocriptine effectively lower prolactin levels, shrink the tumor, and improve symptoms, making B true. Pregnancy is possible with treatment, and annual MRIs are not required if prolactin is controlled.
Question 3 of 5
Most common cause of death in patient's undergoing elective AAA repair is:
Correct Answer: A
Rationale: Cardiovascular events, such as myocardial infarction, are the most common cause of death in elective AAA repair due to underlying atherosclerosis and perioperative stress.
Question 4 of 5
50 yo patient presents with numbness of the first three fingers of the right hand. Which of the following findings on physical exam are supportive of carpal tunnel syndrome?
Correct Answer: A
Rationale: Tinel's sign (symptoms with tapping) is a classic finding in carpal tunnel syndrome, involving median nerve compression.
Question 5 of 5
Which of the following mechanisms best explains how antimetabolites work in cancer treatment?
Correct Answer: D
Rationale: Antimetabolites (e.g., 5-FU, methotrexate) mimic normal substrates, competing for enzyme sites or incorporating into DNA/RNA, disrupting synthesis. Other options describe different drug classes (e.g., topoisomerase inhibitors, tyrosine kinase inhibitors).